Anti-Epileptic Drugs: Global Markets to 2022

  • ID: 4491136
  • Report
  • Region: Global
  • 161 Pages
  • BCC Research
15 % OFF
until Oct 31st 2018
1 of 6
Analyses of Global Market Trends, with Data from 2016 and 2017, and Projections of CAGRs Through 2022

FEATURED COMPANIES

  • Eisai Co., Ltd.
  • Glaxosmithkline Plc
  • Pfizer Inc.
  • Sanofi S.A.
  • UCB S.A.
  • MORE

Report Scope:

This research report categorizes the anti-epileptic drugs market by type. Product type include first generation, second generation and third generation.

Report Includes:

  • 94 data tables
  • An overview of the global anti-epileptic drugs market
  • Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Identification of segments with high growth potential and their future applications
  • Explanation of major drivers and regional dynamics of the market and current trends within the industry
  • Detailed profiles of major vendors in the market, including Eisai Co.Ltd., Glaxosmithkline Plc, Pfizer Inc., Sanofi S.A., UCB S.A

Reasons for Doing This Study:

  • Increasing old age population and rising investments in anti-epileptic drugs manufacturing is driving anti-epileptic drugs manufacturing market globally. Global industry leaders and large organizations see an expanded role for wearable technologies and IoT that help monitor drug delivery in epilepsy patients.
  • The global anti-epileptic drugs manufacturing market is growing due to increasing geriatric population and economic growth. These factors along with research and development of new drugs, modification of existing anti-epileptic drugs is expected to drive the anti-epileptic drugs industry.
  • The market for anti-epileptic drugs is consolidated with a few large players dominating the market. Major players in the market include Pfizer Inc., UCB, GlaxoSmithKline plc, Sanofi, Eisai Co. and others.

Membership Price:

Contact us for membership pricing.

Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Eisai Co., Ltd.
  • Glaxosmithkline Plc
  • Pfizer Inc.
  • Sanofi S.A.
  • UCB S.A.
  • MORE

1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Related Research Reports

2 Summary and Highlights

3 Anti-Epileptic Drugs Market Characteristics

4 Anti-Epileptic Drugs Market Size and Growth

  • Historic Market Growth
  • Drivers of the Market
  • Restraints on the Market
  • Forecast Market Growth
  • Drivers of the Market
  • Restraints on the Market

5 Anti-Epileptic Drugs Market Trends and Strategies

  • Modification of Existing Epilepsy Drugs
  • Collaborations for Anti-Epileptic Drug Development
  • Drug Pipeline

6 PESTLE Analysis

  • Political
  • Economic
  • Social
  • Legal
  • Technological
  • Environmental

7 Anti-Epileptic Drugs Market Segmentation

  • Global Anti-Epileptic Drugs Market, By Segment
  • Global Anti-Epileptic Drugs Market, Historic and Forecast, By Segment, 2013-2022
  • First Generation Anti-Epileptic Drugs Manufacturing
  • Market Characteristics
  • Second Generation Anti-Epileptic Drugs Manufacturing
  • Market Characteristics
  • Third Generation Anti-Epileptic Drugs Manufacturing
  • Market Characteristics

8 Anti-Epileptic Drugs Market Regional and Country Analysis

  • Global Anti-Epileptic Drugs Market, By Region
  • Global Anti-Epileptic Drugs Market, 2013-2022, Historic and Forecast, By Region
  • Global Anti-Epileptic Drugs Market Segmentation, By Region,2017
  • Global Anti-Epileptic Drugs Market, By Country
  • Global Anti-Epileptic Drugs Market, Historic and Forecast, By Country
  • Global Anti-Epileptic Drugs Market Segmentation, 2017, By Country

9 Global Anti-Epileptic Drugs Market Comparison with Macro Economic Factors

  • Global Per Capita Average Anti-Epileptic Drugs Market Expenditure

10 Asia-Pacific Anti-Epileptic Drugs Market

  • Asia-Pacific Anti-Epileptic Drugs Market Overview
  • Region Information
  • Market Information
  • Background Information
  • End User Customer Information
  • Government Initiatives
  • Investments in Anti-Epileptics Drug Manufacturing Market
  • Regulatory Bodies
  • Regulations
  • Taxes Levied
  • Corporate Tax Structure
  • Major Associations
  • Major Companies
  • Asia-Pacific Anti-Epileptic Drugs Market Historic Market, 2013-2017
  • Asia-Pacific Anti-Epileptic Drugs Market Forecast Market
  • Asia-Pacific Anti-Epileptic Drugs Market, By Segment
  • Asia-Pacific Anti-Epileptic Drugs Market, Historic and Forecast CAGR, By Segment

11 Asia-Pacific Anti-Epileptic Drugs Market: Country Analysis

  • China Anti-Epileptic Drugs Market Overview
  • Country Information
  • Market Information
  • Background Information
  • End User Customer Information
  • Government Initiatives
  • Regulatory Bodies
  • Regulations
  • Taxes Levied
  • Corporate Tax Structure
  • Major Associations
  • Major Companies
  • China Anti-Epileptic Drugs Market Historic Market, 2013-2017
  • China Anti-Epileptic Drugs Market Forecast Market, 2017-2022
  • China Market Size, By Segment
  • China Anti-Epileptic Drugs Market, 2013-2022, Historic and Forecast, By Segment
  • India Anti-Epileptic Drugs Market Overview
  • Country Information
  • Market Information
  • Background Information
  • End User Customer Information
  • Government Initiatives
  • Investments in Anti-Epileptics Drug Manufacturing Market
  • Regulatory Bodies
  • Regulations
  • Taxes Levied
  • Corporate Tax Structure
  • Major Associations
  • Major Companies
  • India Anti-Epileptic Drugs Market Historic Market, 2013-2017
  • India Anti-Epileptic Drugs Market Forecast Market, 2017-2022
  • India Market Size, By Segment
  • India Anti-Epileptic Drugs Market, 2013-2022, Historic and Forecast, By Segment
  • Japan Anti-Epileptic Drugs Market Overview
  • Country Information
  • Market Information
  • Background Information
  • End User Customer Information
  • Major Collaborations
  • Government Initiatives
  • Regulatory Bodies
  • Regulations
  • Taxes Levied
  • Corporate Tax Structure
  • Major Associations
  • Major Companies
  • Japan Anti-Epileptic Drugs Market Historic Market, 2013-2017
  • Japan Anti-Epileptic Drugs Market Forecast, 2017-2022
  • Japan Market Size, By Segment
  • Japan Anti-Epileptic Drugs Market, 2013-2022, Historic and Forecast, By Segment
  • Australia Anti-Epileptic Drugs Market
  • Australia Anti-Epileptic Drugs Market Historic Market, 2013-2017
  • Australia Anti-Epileptic Drugs Market Forecast Market, 2017-2022
  • Australia Market Size, By Segment
  • Australia Anti-Epileptic Drugs Market, 2013-2022, Historic and Forecast, By Segment

12 Western Europe Anti-Epileptic Drugs Market

  • Western European Anti-Epileptic Drugs Market Overview
  • Region Information
  • Market Information
  • Background Information
  • New Drug Approvals
  • End User Customer Information
  • Regulatory Bodies
  • Regulations
  • Taxes Levied
  • Corporate Tax Structure
  • Major Associations
  • Major Companies
  • Western Europe Anti-Epileptic Drugs Market Historic Market, 2013-2017
  • Western Europe Anti-Epileptic Drugs Market Forecast Market, 2017-2022
  • Western Europe Market Size, By Segment
  • Western Europe Anti-Epileptic Drugs Market, 2013-2022, Historic and Forecast, By Segment

13 Western Europe Anti-Epileptic Drugs Market: Country Analysis

  • UK Anti-Epileptic Drugs Market Overview
  • Country Information
  • Market information
  • Background Information
  • End User Customer Information
  • Regulatory Bodies
  • Regulations
  • Taxes Levied
  • Corporate Tax Structure
  • Major Associations
  • Major Companies
  • UK Anti-Epileptic Drugs Market Historic Market, 2013-2017
  • UK Anti-Epileptic Drugs Market Forecast Market, 2017-2022
  • UK Market Size, By Segment
  • UK Anti-Epileptic Drugs Market, 2013-2022, Historic and Forecast, By Segment
  • Germany Anti-Epileptic Drugs Market
  • Germany Anti-Epileptic Drugs Market Historic Market, 2013-2017
  • Germany Anti-Epileptic Drugs Market Forecast Market, 2017-2022
  • Germany Market Size, By Segment
  • Germany Anti-Epileptic Drugs Market, 2013-2022, Historic and Forecast, By Segment
  • France Anti-Epileptic Drugs Market
  • France Anti-Epileptic Drugs Market Historic Market, 2013-2017
  • France Anti-Epileptic Drugs Market Forecast Market, 2017-2022
  • France Market Size, By Segment
  • France Anti-Epileptic Drugs Market, Historic and Forecast, By Segment, 2013-2022
  • Italy Anti-Epileptic Drugs Market
  • Italy Anti-Epileptic Drugs Market Historic Market, 2013-2017
  • Italy Anti-Epileptic Drugs Market Forecast Market, 2017-2022
  • Italy Market Size, By Segment
  • Italy Anti-Epileptic Drugs Market, Historic and Forecast, By Segment, 2013-2022,
  • Spain Anti-Epileptic Drugs Market
  • Spain Anti-Epileptic Drugs Market Historic Market, 2013-2017
  • Spain Anti-Epileptic Drugs Market Forecast Market, 2017-2022
  • Spain Market Size, By Segment
  • Spain Anti-Epileptic Drugs Market, Historic and Forecast, By Segment, 2013-2022

14 Eastern Europe Anti-Epileptic Drugs Market

  • Eastern European Anti-Epileptic Drugs Market Overview
  • Region Information
  • Market Information
  • Background Information
  • End User Customer Information
  • Government Initiatives
  • Regulatory Bodies
  • Regulations
  • Taxes Levied
  • Corporate Tax Structure
  • Major Associations
  • Major Companies
  • Eastern Europe Anti-Epileptic Drugs Historic Market, 2013-2017
  • Eastern Europe Anti-Epileptic Drugs Market Forecast, 2017-2022
  • Eastern Europe Market Size, By Segment
  • Eastern Europe Anti-Epileptic Drugs Market, Historic and Forecast, By Segment, 2013-2022

15 Eastern Europe Anti-Epileptic Drugs Market: Country Analysis

  • Russia Anti-Epileptic Drugs Historic Market, 2013-2017
  • Russia Anti-Epileptic Drugs Forecast Market, 2017-2022
  • Russia Market Size, By Segment
  • Russia Anti-Epileptic Drugs Market, Historic and Forecast, By Segment, 2013-2022

16 North America Anti-Epileptic Drugs Market

  • North America Anti-Epileptic Drugs Market Overview
  • Region Information
  • Market Information
  • Background Information
  • New Drug Approvals
  • End User Customer Information
  • Government Initiatives
  • Investments in Anti-Epileptics Market
  • Regulatory Bodies
  • Regulations
  • Taxes Levied
  • Corporate Tax Structure
  • Major Associations
  • Major Companies
  • North America Anti-Epileptic Drugs Historic Market, 2013-2017
  • North America Anti-Epileptic Drugs Market Forecast, 2017-2022
  • North America Market Size, By Segment
  • North America Anti-Epileptic Drugs Market, Historic and Forecast, By Segment, 2013-2022

17 North America Anti-Epileptic Drugs Market: Country Analysis

  • USA Anti-Epileptic Drugs Market
  • USA Anti-Epileptic Drugs Historic Market, 2013-2017
  • USA Anti-Epileptic Drugs Forecast Market, 2017-2022
  • USA Market Size, By Segment
  • USA Anti-Epileptic Drugs Market, 2013-2022, Historic and Forecast, By Segment

18 South America Anti-Epileptic Drugs Market

  • South America Anti-Epileptic Drugs Market Overview
  • Region Information
  • Market Information
  • Background Information
  • New Drug Approvals
  • End User Customer Information
  • Government Initiatives
  • Investments in Anti-Epileptics Market
  • Regulatory Bodies
  • Regulations
  • Taxes Levied
  • Corporate Tax Structure
  • Major Associations
  • Major Companies
  • South America Anti-Epileptic Drugs Historic Market, 2013-2017
  • South America Anti-Epileptic Drugs Forecast Market, 2017-2022
  • South America Market Size, By Segment
  • South America Anti-Epileptic Drugs Historic and Forecast Market, By Segment, 2013-2022

19 South America Anti-Epileptic Drugs Market: Country Analysis

  • Brazil Anti-Epileptic Drugs Market
  • Brazil Anti-Epileptic Drugs Historic Market, 2013-2017
  • Brazil Anti-Epileptic Drugs Forecast Market, 2017-2022
  • Brazil Market Size, By Segment
  • Brazil Anti-Epileptic Drugs Historic and Forecast Market, By Segment, 2013-2022

20 Middle East Anti-Epileptic Drugs Market

  • Middle Anti-Epileptic Drugs Market Overview
  • Region Information
  • Market Information
  • Background Information
  • End User Customer Information
  • Investments in Anti-Epileptic Drugs Market
  • Government Initiatives
  • Regulatory Bodies
  • Regulations
  • Taxes Levied
  • Corporate Tax Structure
  • Major Associations
  • Major Companies
  • Middle East Anti-Epileptic Drugs Historic Market, 2013-2017
  • Middle East Anti-Epileptic Drugs Market Forecast Market, 2017-2022
  • Middle East Market Size, By Segment
  • Middle East Anti-Epileptic Drugs Historic and Forecast Market, By Segment, 2013-2022

21 Africa Anti-Epileptic Drugs Market

  • Africa Anti-Epileptic Drugs Market Overview
  • Region Information
  • Market Information
  • Background Information
  • End User Customer Information
  • Government Initiatives
  • Regulatory Bodies
  • Regulation
  • Taxes Levied
  • Corporate Tax Structure
  • Major Associations
  • Major Companies
  • Africa Anti-Epileptic Drugs Historic Market, 2013-2017
  • Africa Anti-Epileptic Drugs Forecast Market, 2017-2022
  • Africa Market Size, By Segment
  • Africa Anti-Epileptic Drugs Historic and Forecast Market, By Segment, 2013-2022

22 Anti-Epileptic Drugs Market Customer Information

  • Dangers of Pharmaceutical Epilepsy Drug Not Known to Pregnant Women
  • Cannabis Products Help Reduce Epileptic Seizures
  • Performance of Epilepsy Drugs in Elderly Patients
  • Patients with Drug-Refractory Epilepsy Can Benefit from Reducing AED'S

23 Anti-Epileptic Drugs Market Competitive Landscape

  • Company Profiles
  • Eisai Co., LTD.
  • GlaxosmithklinePLC
  • Pfizer INC.
  • Sanofi S.A.
  • UCB S.A.

24 Key Mergers and Acquisitions in the Anti-Epileptic Drugs Market

  • Pfizer Acquired Hospira, Inc.
  • Ferrer Pharma Acquired Alexza Pharmaceuticals
  • Zogenix Acquired Brabant Pharma
  • Sawai Pharmaceutical Acquired Upsher-Smith Laboratories

25 Appendix

  • NAICS Definitions of Industry Covered in This Report
  • Anti-Epileptic Drugs Market
  • Research Methodology

26 References

List of Tables
Summary Table : Global Anti-Epileptic Drugs Market, Through 2022
Table 1 : Global Anti-Epileptic Drugs Historic Market, Through 2017
Table 2 : Global Anti-Epileptic Drugs Market, Through 2022
Table 3 : Global Anti-Epileptic Drugs Market, by Segment, 2017
Table 4 : Global Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Segment, Through 2022
Table 5 : Global Anti-Epileptic Drugs Market, by Region, 2017
Table 6 : Global Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Region, Through 2022
Table 7 : Global Anti-Epileptic Drugs Market, by Region, 2017
Table 8 : Global Anti-Epileptic Drugs Market, by Country, 2017
Table 9 : Global Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Country, 2013-2022
Table 10 : Global Anti-Epileptic Drugs Market, by Country, 2017
Table 11 : Global Per Capita Average Anti-Epileptic Drugs Market Expenditure, 2013-2022
Table 12 : Asia-Pacific-Anti-Epileptic Drugs Historic Market, Through 2017
Table 13 : Asia-Pacific Anti-Epileptic Drugs Forecast Market, Through 2022
Table 14 : Asia-Pacific Anti-Epileptic Drugs Market, by Segment, 2017
Table 15 : Asia-Pacific Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Table 16 : China Anti-Epileptic Drugs Market Historic Market, Through 2017
Table 17 : China Anti-Epileptic Drugs Market, Through 2022
Table 18 : China Anti-Epileptic Drugs Market, by Segments, 2017
Table 19 : China Anti-Epileptic Drugs Market Historic and Forecast Growth Rate, by Segments, 2013-2022
Table 20 : India Anti-Epileptic Drugs Historic Market, Through 2017
Table 21 : India Anti-Epileptic Drugs Forecast Market, Through 2022
Table 22 : India Anti-Epileptic Drugs Market, by Segments, 2017
Table 23 : India Anti-Epileptic Drugs Market Historic and Forecast Growth Rate, by Segments, 2013-2022
Table 24 : Japan Anti-Epileptic Drugs Historic Market, Through 2017
Table 25 : Japan Anti-Epileptic Drugs Market, Through 2022
Table 26 : Japan Anti-Epileptic Drugs Market, by Segments, 2017
Table 27 : Japan Anti-Epileptic Drugs Market Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 28 : Australia Anti-Epileptic Drugs Historic Market, Through 2017
Table 29 : Australia Anti-Epileptic Drugs Market, Through 2022
Table 30 : Australia Anti-Epileptic Drugs Market, by Segment, 2017
Table 31 : Australia Anti-Epileptic Drugs Market Historic and Forecast Growth Rate, by Segments, 2013-2022
Table 32 : Western Europe Anti-Epileptic Drugs Historic Market, Through 2017
Table 33 : Western Europe Anti-Epileptic Drugs Forecast Market, Through 2022
Table 34 : Western Europe Anti-Epileptic Drugs Market, by Segments, 2017
Table 35 : Western Europe Anti-Epileptic Drugs Market Historic and Forecast Growth Rate, by Segments, Through 2022
Table 36 : UK Anti-Epileptic Drugs Historic Market, Through 2017
Table 37 : UK Anti-Epileptic Drugs Forecast Market, Through 2022
Table 38 : UK Anti-Epileptic Drugs Market, by Segments, 2017
Table 39 : UK Anti-Epileptic Drugs Market Historic and Forecast Growth Rate, by Segments, 2013-2022
Table 40 : Germany Anti-Epileptic Drugs Historic Market, Through 2017
Table 41 : Germany Anti-Epileptic Drugs Forecast Market, Through 2022
Table 42 : Germany Anti-Epileptic Drugs Market, by Segments, 2017
Table 43 : Germany Anti-Epileptic Drugs Market Historic and Forecast Growth Rate, by Segments, 2013-2022
Table 44 : France Anti-Epileptic Drugs Historic Market, Through 2017
Table 45 : France Anti-Epileptic Drugs Forecast Market, Through 2022
Table 46 : France Anti-Epileptic Drugs Market, by Segments, 2017
Table 47 : France Anti-Epileptic Drugs Market Historic and Forecast Growth Rate, by Segments, 2013-2022
Table 48 : Italy Anti-Epileptic Drugs Historic Market, Through 2017
Table 49 : Italy Anti-Epileptic Drugs Forecast Market, Through 2022
Table 50 : Italy Anti-Epileptic Drugs Market, by Segments, 2017
Table 51 : Italy Anti-Epileptic Drugs Market Historic and Forecast Growth Rate, by Segments, 2013-2022
Table 52 : Spain Anti-Epileptic Drugs Historic Market, Through 2017
Table 53 : Spain Anti-Epileptic Drugs Forecast Market, 2017-2022
Table 54 : Spain Anti-Epileptic Drugs Market, by Segments, 2017
Table 55 : Spain Anti-Epileptic Drugs Market Historic and Forecast Growth Rate, by Segments, 2013-2022
Table 56 : Eastern Europe Anti-Epileptic Drugs Historic Market, Through 2017
Table 57 : Eastern Europe Anti-Epileptic Drugs Forecast Market, Through 2022
Table 58 : Eastern Europe Anti-Epileptic Drugs Market, by Segments, 2017
Table 59 : Eastern Europe Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 60 : Russia Anti-Epileptic Drugs Historic Market, Through 2017
Table 61 : Russia Anti-Epileptic Drugs ForecastMarket, Through 2022
Table 62 : Russia Anti-Epileptic Drugs Market, by Segment, 2017
Table 63 : Russia Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 64 : North America Anti-Epileptic Drugs Historic Market, Through 2017
Table 65 : North America Anti-Epileptic Drugs Forecast Market, Through 2022
Table 66 : North America Anti-Epileptic Drugs Market, by Segments, 2017
Table 67 : North America Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 68 : USA Anti-Epileptic Drugs Historic Market, Through 2017
Table 69 : USA Anti-Epileptic Drugs Forecast Market, Through 2022
Table 70 : USA Anti-Epileptic Drugs Market, by Segment, 2017
Table 71 : USA Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Segments, Through 2022
Table 72 : South America Anti-Epileptic Drugs Historic Market, Through 2017
Table 73 : South America Anti-Epileptic Drugs Forecast Market, Through 2022
Table 74 : South America Anti-Epileptic Drugs Market, by Segments, 2017
Table 75 : South America Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Segment, Through 2022
Table 76 : Brazil Anti-Epileptic Drugs Historic Market, Through 2017
Table 77 : Brazil Anti-Epileptic Drugs Forecast Market, Through 2022
Table 78 : Brazil Anti-Epileptic Drugs Market, by Segment, 2017
Table 79 : Brazil Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 80 : Middle East Anti-Epileptic Drugs Historic Market, Through 2017
Table 81 : Middle East Anti-Epileptic Drugs Forecast Market, Through 2022
Table 82 : Middle East Anti-Epileptic Drugs Market, by Segments, 2017
Table 83 : Middle East Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 84 : Africa Anti-Epileptic Drugs Historic Market, 2013-2017
Table 85 : Africa Anti-Epileptic Drugs Forecast Market, Through 2022
Table 86 : Africa Anti-Epileptic Drugs Market, by Segment, 2017
Table 87 : Africa Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 88 : Global Market Shares for Key Competitors of Anti-Epileptic Drugs Market, 2017
Table 89 : Eisai Co., Ltd. Financial Performance, 2013-2016
Table 90 : GlaxoSmithKline PLC Financial Performance, 2013-2016
Table 91 : Pfizer Inc. Financial Performance, 2013-2017
Table 92 : Sanofi S.A. Financial Performance, 2013-2016
Table 93 : UCB S.A. Financial Performance, 2013-2017
Table 94 : Market Data Sources

List of Figures
Summary Figure : Global Anti-Epileptic Drugs Market, 2017-2022
Figure 1 : Global Anti-Epileptic Drugs Historic Market, 2013-2017
Figure 2 : Global Anti-Epileptic Drugs Market, 2017-2022
Figure 3 : PESTLE Analysis: Global Anti-Epileptic Drugs Market, 2017
Figure 4 : Global Anti-Epileptic Drugs Market Share, by Segments, 2017
Figure 5 : Global Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 6 : Global Anti-Epileptic Drugs Market Share, by Region, 2017
Figure 7 : Global Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Region, 2013-2022
Figure 8 : Global Anti-Epileptic Drugs Market, by Region, 2017
Figure 9 : Global Anti-Epileptic Drugs Market, by Country, 2017
Figure 10 : Global Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Country, 2013-2022
Figure 11 : Global Anti-Epileptic Drugs Market, by Country, 2017
Figure 12 : Global Per Capita Average Anti-Epileptic Drugs Market Expenditure, 2013-2022
Figure 13 : Asia-Pacific Anti-Epileptic Drugs Historic Market, 2013-2017
Figure 14 : Asia-Pacific Anti-Epileptic Drugs Forecast Market, 2017-2022
Figure 15 : Asia-Pacific Anti-Epileptic Drugs Market Share, by Segment, 2017
Figure 16 : Asia-Pacific Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 17 : China Anti-Epileptic Drugs Market Historic Market, 2013-2017
Figure 18 : China Anti-Epileptic Drugs Market, 2017-2022
Figure 19 : China Anti-Epileptic Drugs Market Share, by Segments, 2017
Figure 20 : China Anti-Epileptic Drugs Market Historic and Forecast Growth Rate, by Segments, 2013-2022
Figure 21 : India Anti-Epileptic Drugs Historic Market, 2013-2017
Figure 22 : India Anti-Epileptic Drugs Forecast Market, 2017-2022
Figure 23 : India Anti-Epileptic Drugs Market Share, by Segment, 2017
Figure 24 : India Anti-Epileptic Drugs Market Historic and Forecast Growth Rate, by Segments, 2013-2022
Figure 25 : Japan Anti-Epileptic Drugs Historic Market, 2013-2017
Figure 26 : Japan Anti-Epileptic Drugs Market, 2017-2022
Figure 27 : Japan Anti-Epileptic Drugs Market Share, by Segments, 2017
Figure 28 : Japan Anti-Epileptic Drugs Market Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 29 : Australia Anti-Epileptic Drugs Historic Market, 2013-2017
Figure 30 : Australia Anti-Epileptic Drugs Market, 2017-2022
Figure 31 : Australia Anti-Epileptic Drugs Market Share, by Segments, 2017
Figure 32 : Australia Anti-Epileptic Drugs Market Historic and Forecast Growth Rate, by Segments, 2013-2022
Figure 33 : Western Europe Anti-Epileptic Drugs Historic Market, 2013-2017
Figure 34 : Western Europe Anti-Epileptic Drugs Forecast Market, 2017-2022
Figure 35 : Western Europe Anti-Epileptic Drugs Market Share, by Segments, 2017
Figure 36 : Western Europe Anti-Epileptic Drugs Market Historic and Forecast Growth Rate, by Segments, 2013-2022
Figure 37 : UK Anti-Epileptic Drugs Historic Market, 2013-2017
Figure 38 : UK Anti-Epileptic Drugs Forecast Market, 2017-2022
Figure 39 : UK Anti-Epileptic Drugs Market Share, by Segments, 2017
Figure 40 : UK Anti-Epileptic Drugs Market Historic and Forecast Growth Rate, by Segments, 2013-2022
Figure 41 : Germany Anti-Epileptic Drugs Historic Market, 2013-2017
Figure 42 : Germany Anti-Epileptic Drugs Forecast Market, 2017-2022
Figure 43 : Germany Anti-Epileptic Drugs Market Share, by Segments, 2017
Figure 44 : Germany Anti-Epileptic Drugs Market Historic and Forecast Growth Rate, by Segments, 2013-2022
Figure 45 : France Anti-Epileptic Drugs Historic Market, 2013-2017
Figure 46 : France Anti-Epileptic Drugs Forecast Market, 2017-2022
Figure 47 : France Anti-Epileptic Drugs Market Share, by Segment, 2017
Figure 48 : France Anti-Epileptic Drugs Market Historic and Forecast Growth Rate, by Segments, 2013-2022
Figure 49 : Italy Anti-Epileptic Drugs Historic Market, 2013-2017
Figure 50 : Italy Anti-Epileptic Drugs Forecast Market, 2017-2022
Figure 51 : Italy Anti-Epileptic Drugs Market Share, by Segment, 2017
Figure 52 : Italy Anti-Epileptic Drugs Market Historic and Forecast Growth Rate, by Segments, 2013-2022
Figure 53 : Spain Anti-Epileptic Drugs Historic Market, 2013-2017
Figure 54 : Spain Anti-Epileptic Drugs Forecast Market, 2017-2022
Figure 55 : Spain Anti-Epileptic Drugs Market Share, by Segments, 2017
Figure 56 : Spain Anti-Epileptic Drugs Market Historic and Forecast Growth Rate, by Segments, 2013-2022
Figure 57 : Eastern Europe Anti-Epileptic Drugs Historic Market, 2013-2017
Figure 58 : Eastern Europe Anti-Epileptic Drugs Forecast Market, 2017-2022
Figure 59 : Eastern Europe Anti-Epileptic Drugs Market Share, by Segment, 2017
Figure 60 : Eastern Europe Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 61 : Russia Anti-Epileptic Drugs Historic Market, 2013-2017
Figure 62 : Russia Anti-Epileptic Drugs Forecast Market, 2017-2022
Figure 63 : Russia Anti-Epileptic Drugs Market, by Segment, 2017
Figure 64 : Russia Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 65 : North America Anti-Epileptic Drugs Historic Market, 2013-2017
Figure 66 : North America Anti-Epileptic Drugs Forecast Market, 2017-2022
Figure 67 : North America Anti-Epileptic Drugs Market Share, by Segment, 2017
Figure 68 : North America Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 69 : USA Anti-Epileptic Drugs Historic Market, 2013-2017
Figure 70 : USA Anti-Epileptic Drugs Forecast Market, 2017-2022
Figure 71 : USA Anti-Epileptic Drugs Market Share, by Segment, 2017
Figure 72 : USA Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 73 : South America Anti-Epileptic Drugs Historic Market, 2013-2017
Figure 74 : South America Anti-Epileptic Drugs Forecast Market, 2017-2022
Figure 75 : South America Anti-Epileptic Drugs Market Share, by Segments, 2017
Figure 76 : South America Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 77 : Brazil Anti-Epileptic Drugs Historic Market, 2013-2017
Figure 78 : Brazil Anti-Epileptic Drugs Forecast Market, 2017-2022
Figure 79 : Brazil Anti-Epileptic Drugs Market Share, by Segment, 2017
Figure 80 : Brazil Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 81 : Middle East Anti-Epileptic Drugs Historic Market, 2013-2017
Figure 82 : Middle East Anti-Epileptic Drugs Forecast Market, 2017-2022
Figure 83 : Middle East Anti-Epileptic Drugs Market Share, by Segments, 2017
Figure 84 : Middle East Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 85 : Africa Anti-Epileptic Drugs Historic Market, 2013-2017
Figure 86 : Africa Anti-Epileptic Drugs Forecast Market, 2017-2022
Figure 87 : Africa Anti-Epileptic Drugs Market Share, by Segments, 2017
Figure 88 : Africa Anti-Epileptic Drugs Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 89 : Global Market Shares for Key Competitors of Anti-Epileptic Drugs Market, 2017
Figure 90 : Eisai Co., Ltd. Financial Performance, 2013-2016
Figure 91 : GlaxoSmithKline PLC Financial Performance, 2013-2016
Figure 92 : Pfizer Inc. Financial Performance, 2013-2017
Figure 93 : Sanofi S.A. Financial Performance, 2013-2016
Figure 94 : UCB S.A. Financial Performance, 2013-2017

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Eisai Co., Ltd.
  • Glaxosmithkline Plc
  • Pfizer Inc.
  • Sanofi S.A.
  • UCB S.A.
  • MORE

Summary:

  • Global anti-epileptic drugs manufacturing market growth outlook is positive with significant growth potential for anti-epileptic drugs. Emerging market growth, rising old age population, increasing incidences of accidents globally is driving the demand for anti-epileptic drugs. At the same time, there is mounting pressure on anti-epileptic drugs manufacturers to reduce costs, minimize side effects and improve drugs quality.
  • The market for anti-epileptic drugs is somewhat concentrated with a few large players dominating the market. Major players in the market are Pfizer Inc., UCB, GlaxoSmithKline plc, Sanofi, Eisai Co. and others. The highest growth is projected to come from third generation anti-epileptic drugs. Major factors included economic growth and technological advancements. The USA is the largest market in terms of value in the anti-epileptic drugs market.
  • The market is challenged by restraints such as stringent regulations, high research and development costs and rising trade protectionism.
Note: Product cover images may vary from those shown
5 of 6
  • Eisai Co., Ltd.
  • Glaxosmithkline Plc
  • Pfizer Inc.
  • Sanofi S.A.
  • UCB S.A.
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll